IRIS PubliCatt

Pierconti, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.972
NA - Nord America 2.804
AS - Asia 693
AF - Africa 22
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 6.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.791
IT - Italia 843
SE - Svezia 626
DE - Germania 519
CN - Cina 372
PL - Polonia 279
SG - Singapore 178
UA - Ucraina 169
IE - Irlanda 143
FR - Francia 123
GB - Regno Unito 69
RU - Federazione Russa 69
IN - India 54
FI - Finlandia 51
TR - Turchia 45
BE - Belgio 27
CI - Costa d'Avorio 16
IR - Iran 14
CA - Canada 11
CH - Svizzera 10
NL - Olanda 9
ES - Italia 7
JP - Giappone 7
VN - Vietnam 7
AT - Austria 6
AR - Argentina 5
BR - Brasile 5
HK - Hong Kong 5
MA - Marocco 5
AU - Australia 4
KR - Corea 4
NO - Norvegia 4
RO - Romania 4
EU - Europa 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CM - Camerun 1
DK - Danimarca 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PK - Pakistan 1
TW - Taiwan 1
Totale 6.517
Salva come PNG Salva come JPEG
Città #
Chandler 570
Warsaw 266
Ashburn 239
Dublin 142
Ann Arbor 127
Singapore 124
Fairfield 117
Milan 116
San Mateo 111
Jacksonville 104
Wilmington 104
Rome 96
Nanjing 93
Seattle 83
New York 78
Houston 68
Woodbridge 66
Dearborn 59
Moscow 56
Princeton 52
Beijing 47
Boston 47
Chicago 46
Redmond 43
Izmir 41
Bremen 40
Los Angeles 34
Marseille 34
Nanchang 34
Cattolica 31
Lawrence 28
Cambridge 26
Nürnberg 24
Verona 24
Brussels 23
Redwood City 21
Enterprise 18
Mountain View 18
Munich 18
Florence 17
Kunming 17
Shenyang 17
Abidjan 16
Bari 16
Hangzhou 16
Naples 16
Bologna 15
Helsinki 15
Tianjin 14
Falls Church 13
Hebei 13
Boardman 12
Jiaxing 12
Kraków 12
Genoa 11
Palermo 11
Augusta 9
Miami 9
Shanghai 9
Turin 8
Edinburgh 7
Fremont 7
Guangzhou 7
Lancaster 7
Norwalk 7
Pune 7
Andover 6
Berlin 6
Casignana 6
Catania 6
Changsha 6
Jinan 6
Kish 6
Orange 6
University Park 6
Washington 6
Changchun 5
Dong Ket 5
Gonzalez Catan 5
Gunzenhausen 5
London 5
Mumbai 5
Oujda 5
Richmond 5
Vienna 5
Alba 4
Ardabil 4
Ferrara 4
Hong Kong 4
Hounslow 4
Madrid 4
Messina 4
Montanaso Lombardo 4
Montefano 4
Philadelphia 4
Reggio Calabria 4
Serracapriola 4
Tokyo 4
Treviso 4
Zhengzhou 4
Totale 3.753
Salva come PNG Salva come JPEG
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 692
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 322
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 204
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 195
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 169
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 164
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 144
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 138
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 124
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 118
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 117
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 112
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 108
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 106
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 102
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 101
Metabolic reprogramming by malat1 depletion in prostate cancer 101
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 97
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 97
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 87
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 82
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 81
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 81
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 79
Bladder and prostate metastasis from small cell lung cancer: a rare entity 79
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 73
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 72
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 71
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 71
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 70
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 69
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 69
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 68
Olfactory receptors in semen and in the male tract: From proteome to proteins 68
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 66
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 66
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 62
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 61
Giant spermatic cord liposarcoma 60
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 60
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 58
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 58
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 57
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 57
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 57
Proteomics for the identification of biomarkers in testicular cancer–review 55
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 55
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 53
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 53
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 53
Methylation study of the Paris system for reporting urinary (TPS) categories 53
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 53
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 52
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 52
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 51
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 50
Biomarkers of response to advanced prostate cancer therapy 50
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 49
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 48
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 47
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 47
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 47
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 46
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 46
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 45
Mesenchymal differentiation of glioblastoma stem cells 44
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 44
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 42
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 37
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 33
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 31
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 29
Mesenchymal differentiation of glioblastoma stem cells 28
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 28
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 27
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 25
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 25
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 23
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 21
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 20
Extremely delayed falx metastasis from renal cell carcinoma 20
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 19
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 19
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 17
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 17
p53 expression in cytology samples may represent a marker of early-stage cancer 14
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 13
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 11
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 11
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 11
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 10
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 10
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 10
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 9
Metastasis to the renal hilum from malignant melanoma of the anterior trunk: An unusual finding 9
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 8
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 7
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 7
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 4
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 3
Totale 6.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020632 0 0 50 64 45 63 80 36 67 32 129 66
2020/2021760 85 113 56 56 80 58 47 13 68 43 123 18
2021/2022860 76 39 27 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/20241.194 79 227 62 75 89 158 93 61 24 84 104 138
2024/2025192 70 61 61 0 0 0 0 0 0 0 0 0
Totale 6.687